COVID-19 Key EU Developments, Policy & Regulatory Update No. 99
This regular update (no. 99 | 17 March 2023) covers key regulatory EU developments related to the evolving COVID-19 situation (Antitrust & State Aid; Trade/Export Controls; Medicines, Medical Devices and Personal Protective Equipment; and Cybersecurity, Privacy & Data Protection).
Lucie Fournier (Associate), Cecelia Kye (Consultant), and Justine Naessens (Associate) in the Brussels Office contributed to this Update.
This COVID-19 Update will soon be transitioning to the new EU Emergency Response Update – Key Policy & Regulatory Developments, which will continue to cover key regulatory developments related to EU emergency responses, including in particular, to the COVID-19 and Ukraine-Russia situations.
Insights by Jones Day should not be construed as legal advice on any specific facts or circumstances. The contents are intended for general information purposes only and may not be quoted or referred to in any other publication or proceeding without the prior written consent of the Firm, to be given or withheld at our discretion. To request permission to reprint or reuse any of our Insights, please use our “Contact Us” form, which can be found on our website at www.jonesday.com. This Insight is not intended to create, and neither publication nor receipt of it constitutes, an attorney-client relationship. The views set forth herein are the personal views of the authors and do not necessarily reflect those of the Firm.
